The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: A preliminary study

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2363-2370

  Streckfus, Charles ^a   Bigler, Lenora ^c   Dellinger, Tracy ^b   Dai, Xaoli ^a   Kingman, Albert ^d   Thigpen, J Tate ^c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; SALIVA PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SALIVA LEVEL; TUMOR BIOPSY;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOMA; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASS SCREENING; MENOPAUSE; MIDDLE AGED; PILOT PROJECTS; RECEPTOR, ERBB-2; SALIVA; SENSITIVITY AND SPECIFICITY; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 0034096263     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ouyang, X., Gulliford, T., Doherty, A., Huang, G., and Epstein, R. Detection of ErbB-2 oversignalling in a majority of breast cancers with phosphorylation-state-specific antibodies. Lancet, 353: 1591-1592, 1999.
2. Ross, J. S., and Fletcher, J. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells, 16: 413-428, 1998.
3. Koscielny, S., Terrier, P., Spielmann, M., and Delarue, J. C. Prognostic importance of low c-erbB-2 expression in breast tumors. J. Natl. Cancer Inst., 90: 712, 1998.
4. Volas, G. H., Leitzel, K., Teramoto, Y., Grossber, H., Demeres, L., and Lipton, A. Serial serum c-erbB-2 levels in patients with breast carcinoma. Cancer, 78: 267-272, 1996.
5. Breuer, B., Smith, S., Thor, A., Edgerton, S., Osborne, M., Minick, R., Cody, H., Nowak, E., Cortese, A., Simmons, R., Carney, W., and Brandt-Rauf, P. ErbB-2 protein in sera and tumors of breast cancer patients. Breast Cancer Res. Treat., 49: 261-270, 1998.
6. Krainer, M., Brodowicz, T., Zeillenger, R., Wiltschke, C., Scholten, C., Seifert, M., Kubista, E., and Zielinski, C. Tissue expression and serum levels of HER-2/neu in patients with breast cancer. Oncology, 54: 475-481, 1997.
7. Streckfus, C. F., Bigler, L., Tucci, M., and Thigpen, J. T. The presence of CA 15-3, c-erbB-2, EGFR, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Investig., 18: 2, 101-109, 2000.
8. Staging for carcinoma of the breast. In: I. D. Fleming, J. S. Cooper, D. E. Henson, R. V. Hutter, B. J. Kennedy, G. P. Murphy, B. O'Sullivan, L. H. Sobin, J. W. Yarbro, (eds.), AJCC Cancer Staging Manual, pp. 171-180, 5th Ed. Philadelphia: J. B. Lippincott-Raven, 1998.
9. Mandel, I. D. The diagnostic uses of saliva. J. Oral Pathol. Med., 19: 119-125, 1990.
10. Navasesh, M., and Christensen, C. A comparison of whole mouth resting and stimulated salivary measurements. J. Dent. Res., 61: 1158-1162, 1982.
11. Molina, R., Zanon, G., and Filella, X. et al. Use of serial carcinoembryonic antigen and CA 15-3 assays in detecting relapses in breast cancer patients. Breast Cancer Res. Treat., 36: 41-48, 1995.
12. SPSS for Windows, Release 9.0. Chicago: SPSS, 1999.
13. Thompson, M. L., and Zucchini, W. On the statistical analysis of ROC curves. Stat. Med., 8: 1277-1290, 1989.
14. Wilcosky, T. C. Criteria for selecting and evaluating markers. In: B. S. Hulka, T. C. Wilcosky, and J. D. Griffith (eds), Biological Markers in Epidemiology, pp. 36-42. New York: Oxford University Press, 1990.
15. Dawson-Saunders, B., and Trapp, R. C. Basic and Clinical Biostatistics, pp. 243-245. Norwalk, CT: Appleton and Lange, 1994.
16. CIS Bio International. Enzyme immunoassay of CA 15-3. Bedford, MA: CIS Bio International, 1999.
17. Stenman, U. H., and Heikkinen, R. Serum markers for breast cancer. Scand. J. Clin. Lab. Investig., 206 (Suppl.): 52-59, 1991.
18. Safi, F., Kohler, I., Röttinger, E., and Berger, H. G. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. Cancer (Phila.), 68: 574-582, 1991.
19. Colomer, R., Ruibal, A., and Salvador, L. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Cancer (Phila.), 64: 1674-1681, 1989.
20. Kallioniemi, O. P., Oksa, H., Aaran, R. K., Hietanan, T., Lehtinen, M., and Koivula, T. Serum CA 15-3 assay in diagnosis and follow-up breast cancer. Br. J. Cancer, 58: 213-215, 1988.
21. Narita, T., Funahashi, H., Satoh, Y., and Takagi, H. c-erbB-2 protein in the sera of breast cancer patients. Breast Cancer Res. Treat., 24: 97-102, 1992.
22. Leitzel, K., Teramoto, Y., Sampson, E., Mauceri, J., Langton, B. C., Demers, L., Podczaski, E., Harvey, H., Shambaugh, S., Volas, G., et al. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. J. Clin. Oncol., 10: 1436-1443, 1992.
23. Breuer, B., Luo, J. C., DeVivo, I., Smith, S., Pincus, M. R., Tatum, A. H., Daucher, J., et al. Detection of elevated c-erbB-2 oncoprotein in serum and tissue in breast cancer. Med. Sci. Res., 21: 383-384, 1993.
24. Breuer, B., DeVivo, I., Luo, J. C., Smith, S., Pincus, M. R., Tatum, A. H., Daucher, J., Minick, C. R., Miller, D., Nowak, E. J., Cody, H. S., III, Nimar, H., Carney, W. P., and Brandt-Rauf, P. W. c-erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients. Cancer Epidemiol. Biomark. Prev., 3: 63-66, 1994.
25. Watanabe, N., Miyamoto, M., Tokuda, Y., Kubota, M., Ando, Y., Tajima, T., and Mitomi, T. Serum c-erbB-2 in breast cancer patients. Acta Oncol., 33: 901-904, 1994.
26. Kynast, B., Binder, L., Marx, D., Zoll, B., Schmoll, H. J., Oellerich, M., and Schaur, A. Determination of a fragment of the c-erbB-2 translation product p185 in serum of breast cancer patients. Cancer Res. Clin. Oncol., 119: 249-252, 1993.
27. Streckfus, C. F., Bigler, L., Dellinger, T. M., Pfeifer, M. R., Rose, A., and Thigpen, J. T. CA 15-3, and c-erbB-2 presence in the saliva of women. Clin. Oral Investig., 3: 138-143, 1999.
28. McIntyre, R., Bigler, L., Dellinger, T. M., Pfeifer, M. R., Mannery, T., and Streckfus, C. F. Oral contraceptive use does not alter the expression of CA 15-3 and c-erbB-2 in the saliva of healthy women. Oral Surg. Oral Med. Oral Pathol., 88: 687-690, 1999.